SATELLOS BIOSCIENCE INC (MSCL.CA) Stock Price, Quote, News and Overview
TSX-V:MSCL - TSX Venture Exchange - CA45107J1057 - Common Stock - Currency: CAD
MSCL.CA Quote, Performance and Key Statistics
TSX-V:MSCL (2/21/2025, 7:00:00 PM)
0.78
+0.01 (+1.3%)
The current stock price of MSCL.CA is 0.78 CAD. In the past month the price decreased by -11.36%. In the past year, price increased by 16.42%.
MSCL.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 261.54M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 188.23M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 185.09M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 121.39M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 89.95M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 82.42M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 25.45 | 76.72M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 48.5 | 65.22M | ||
| MDCX.CA | MEDICUS PHARMA LTD | N/A | 61.74M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 52.45M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 51.96M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 25.50M |
Related stock screener links
About MSCL.CA
Company Profile
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. The company is headquartered in Toronto, Ontario and currently employs 3 full-time employees. The company went IPO on 2006-12-01. The firm is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.
Company Info
SATELLOS BIOSCIENCE INC
79 Wellington Street West, 33rd Floor
TORONTO ONTARIO CA
Employees: 3
Company Website: https://satellos.com/
Phone: 16476601780
SATELLOS BIOSCIENCE INC / MSCL.CA FAQ
What is the stock price of SATELLOS BIOSCIENCE INC today?
The current stock price of MSCL.CA is 0.78 CAD. The price increased by 1.3% in the last trading session.
What is the ticker symbol for SATELLOS BIOSCIENCE INC stock?
The exchange symbol of SATELLOS BIOSCIENCE INC is MSCL and it is listed on the TSX Venture Exchange exchange.
On which exchange is MSCL.CA stock listed?
MSCL.CA stock is listed on the TSX Venture Exchange exchange.
What is SATELLOS BIOSCIENCE INC worth?
SATELLOS BIOSCIENCE INC (MSCL.CA) has a market capitalization of 78.27M CAD. This makes MSCL.CA a Micro Cap stock.
How many employees does SATELLOS BIOSCIENCE INC have?
SATELLOS BIOSCIENCE INC (MSCL.CA) currently has 3 employees.
What are the support and resistance levels for SATELLOS BIOSCIENCE INC (MSCL.CA) stock?
SATELLOS BIOSCIENCE INC (MSCL.CA) has a support level at 0.74 and a resistance level at 0.89. Check the full technical report for a detailed analysis of MSCL.CA support and resistance levels.
Should I buy SATELLOS BIOSCIENCE INC (MSCL.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MSCL.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MSCL.CA, evaluating the profitability, health, valuation and growth aspects
- SATELLOS BIOSCIENCE INC (MSCL.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SATELLOS BIOSCIENCE INC (MSCL.CA) Sales and EPS estimates to see what analysts future expectations are.
- SATELLOS BIOSCIENCE INC (MSCL.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SATELLOS BIOSCIENCE INC (MSCL.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- SATELLOS BIOSCIENCE INC (MSCL.CA) Stock Chart to make your own analysis
- SATELLOS BIOSCIENCE INC (MSCL.CA) Latest news and press-releases to stay up to date.
Does SATELLOS BIOSCIENCE INC (MSCL.CA) stock pay dividends?
MSCL.CA does not pay a dividend.
MSCL.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to MSCL.CA. When comparing the yearly performance of all stocks, MSCL.CA turns out to be only a medium performer in the overall market: it outperformed 64.79% of all stocks.
MSCL.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MSCL.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to MSCL.CA. The Buy consensus is the average rating of analysts ratings from 7 analysts.